Intestinibacter

Taxonomy and Classification#

Type species of the genus Intestinibacter; reclassified from Clostridium bartlettii based on 16S rRNA phylogenetics. Family Peptostreptococcaceae, order Clostridiales, class Clostridia. The name Intestinibacter ("gut bacterium") reflects its primary ecological niche—it is a gut-adapted organism that only occasionally causes opportunistic infections.

The genus was separated from Clostridium to accommodate its distinct phylogenetic position among the diverse Clostridiales lineages now known to be paraphyletic in the original taxonomy.

Spore-Forming Biology#

A defining feature of I. bartlettii is its capacity to form endospores—heat-resistant, oxygen-tolerant, dehydration-tolerant dormant structures.

Endospore formation enables survival during aerobic exposure, antibiotic treatment courses, starvation, and transit through the harsh upper GI environment. Once established in the colon, spore-formers are difficult to permanently eradicate because spores can persist through antibiotic courses and germinate when conditions improve.

This persistence mechanism likely explains why Intestinibacter can be found in a wide range of disease states despite being a strict anaerobe—its spores may accumulate in dysbiotic environments where other obligate anaerobes are eliminated.

Spore coat proteins require iron and cobalt cofactors during spore formation; metal availability during sporulation may influence spore dormancy characteristics.

Metal Dependencies#

Iron. Ferredoxin-dependent oxidoreductases in the central anaerobic metabolism of Clostridiales require iron as an electron carrier. In I. bartlettii, these enzymes support fatty acid metabolism and energy generation from complex carbohydrates.

Iron-dependent sporulation machinery: the sigma factor cascade controlling sporulation in Clostridium-related species involves iron-dependent regulatory proteins.

Cobalt. Cobalt-containing corrinoid (cobalamin/B12-like) enzymes participate in one-carbon metabolism and methionine biosynthesis via cobalt-dependent methionine synthase.

Corrinoid-dependent metabolism is characteristic of many Clostridiales; it enables I. bartlettii to generate methyl donors for DNA methylation and SAM-dependent reactions, potentially influencing host epigenetic responses to microbial metabolites.

Cardiovascular Disease: Protective Role#

Bidirectional Mendelian randomization provides causal evidence for a protective effect of Intestinibacter against multiple CVD outcomes.^{[1]Assessment of the causal relationship between gut microbiota and cardiovascular diseases: a bidirectional Mendelian randomization analysisXiao-Ce Dai, Yi Yu, Si-Yu Zhou et al. · 2024Open reference 1 ↓}

Atrial fibrillation: Genetically predicted higher Intestinibacter abundance is protective (OR = 0.908, 95% CI calculated from GWAS summary statistics). Coronary artery disease: Protective effect independently supported (OR = 0.919).

Intestinibacter is grouped with other butyrate-producing taxa (Coprococcus, Ruminiclostridium) as metal-sensitive protective organisms—taxa that are among those most vulnerable to depletion by heavy metal exposure.

The proposed mechanism for CVD protection involves short-chain fatty acid (particularly butyrate) production, which reduces systemic inflammation and may directly protect vascular endothelium from oxidative damage.

These protective taxa being metal-sensitive means that metal-induced dysbiosis could selectively remove cardiovascular protection—a pattern consistent with the epidemiological association between heavy metal exposure and cardiovascular disease risk.

Colorectal Cancer: Causal Risk Factor#

In contrast to its CVD-protective role, MR evidence identifies Intestinibacter as a causal risk factor for CRC with the strongest individual effect size among tested genera.^{[2]Identification of Host Gene-Microbiome Associations in Colorectal Cancer Patients Using Mendelian RandomizationXiang Y, Zhang C, Wang J et al. · 2023Open reference 2 ↓}

OR = 1.31 (P = 0.0038)—the largest causal risk effect identified in this genome-microbiome-CRC analysis. Replicated in an independent FinnGen validation cohort, supporting robustness beyond the discovery dataset. Meta-analysis combining Australian Gut Wide Association Study (AGWAS) and FinnGen results confirmed the causal association after multiple testing correction.

The paradox—protective in CVD but harmful in CRC—may reflect. Tissue-specific metabolic effects: Butyrate is anti-inflammatory in the vascular endothelium but has complex dose-dependent effects on colonocyte proliferation—extremely high local butyrate production near the colonic epithelium could theoretically promote proliferation.

Spore-mediated immune modulation: Spore surface components may interact with colonic innate immune receptors differently from vegetative cell wall components, potentially suppressing anti-tumor surveillance.

Metabolic byproduct toxicity: Clostridiales-class fermentation can generate reactive metabolites (e.g., secondary bile acid deoxycholate precursors) that are directly genotoxic to colonocytes at high concentrations.

Graves' Disease: Risk Factor#

A Mendelian randomization study of the gut-thyroid axis identified Intestinibacter as a causal risk factor for Graves' disease (OR = 1.777, P < 0.001—the strongest individual risk effect in this study).^{[3]Zheng 2025 — Gut-thyroid axis causality with AITD: bidirectional Mendelian randomizationTing Zheng, Xin Li, Hongyu Xiang · 2025Open reference 3 ↓}

The association is highly specific: Intestinibacter is a Graves' disease risk factor but the evidence for Hashimoto's thyroiditis uses different risk taxa (Intestinimonas, a related but distinct genus).

Reverse MR showed no evidence of Graves' disease causally altering gut microbiota composition—directionality is microbiome → thyroid autoimmunity.

The mechanism linking Intestinibacter to autoimmune thyroid disease may involve molecular mimicry (Clostridiales antigens cross-reacting with thyroid antigens), immune dysregulation via metabolite production, or spore-component stimulation of autoreactive T cell populations.

Metabolic and Dietary Associations#

Metformin sensitivity: Decreased by metformin treatment in type 2 diabetes patients,^{[4]Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drugHao Wu, Eduardo Esteve, Valentina Tremaroli et al. · 2017Open reference 4 ↓} and in healthy young Danish men receiving metformin^{[5]Bryrup 2019 — Metformin-Induced Changes of the Gut Microbiota in Healthy Young Men: Results of a Non-Blinded, One-Armed Intervention StudyThomas Bryrup, Cecilie W. Thomsen, Timo Kern et al. · 2019Open reference 5 ↓}—a finding that is reversible upon treatment cessation, confirming the metabolic rather than permanent nature of the effect.

Dietary fiber metabolism: Linked to starch degradation pathways in the context of functional diet studies of Multiple Sclerosis, where I. bartlettii was associated with dietary fiber metabolism.^{[6]Functional Microbiome Reprogramming Links Dietary Interventions to Neuroinflammatory Outcomes in Multiple SclerosisFriederike Gutmann, Lina Samira Bahr, Ulrike Bruning et al. · 2025Open reference 6 ↓}

The metformin sensitivity may explain part of the drug's reported cancer-preventive effect: reducing Intestinibacter as a CRC-risk taxon could be one mechanism among several.